Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies. (Q53226503)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2006

Language	Label	Description	Also known as
English	Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.	scientific article published in October 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

author name string

David J Straus

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

Marcia A Testa

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

Brenda J Sarokhan

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

Myron S Czuczman

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

Anil Tulpule

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

Ralph R Turner

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

Shirley A Riggs

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

language of work or name

0 references

publication date

1 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

107

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

1909-1917

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

21 January 2018

The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of hemoglobin levels on fatigue and quality of life in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

The level of haemoglobin in anaemic cancer patients correlates positively with quality of life

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22221

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22221

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16977654

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53226503&oldid=1424755494"